Researchers from Penn, in collaboration with the Ragon Institute, develop a new dual CAR T cell immunotherapy that combats HIV infection in humanized mice
Largest-ever study of its kind finds variants that may predispose some to develop the disease and related conditions
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.